The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; none of the 32 sources its claims cite is checked for support yet.
YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs
Open accessAbstract
N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic messenger RNA (mRNA) and plays critical roles in RNA biology. The function of this modification is mediated by m6A-selective ‘reader’ proteins of the YTH family, which incorporate m6A-modified mRNAs into pathways of RNA metabolism. Here, we show that the m6A-binding protein YTHDC1 mediates export of methylated mRNA from the nucleus to the cytoplasm in HeLa cells. Knockdown of YTHDC1 results in an extended residence time for nuclear m6A-containing mRNA, with an accumulation of transcripts in the nucleus and accompanying depletion within the cytoplasm. YTHDC1 interacts with the splicing factor and nuclear export adaptor protein SRSF3, and facilitates RNA binding to both SRSF3 and NXF1. This role for YTHDC1 expands the potential utility of chemical modification of mRNA, and supports an emerging paradigm of m6A as a distinct biochemical entity for selective processing and metabolism of mammalian mRNAs.
Overview
CoChat Summary
TL;DR
YTHDC1, a nuclear m6A reader, mediates nuclear-to-cytoplasmic export of methylated mRNAs in HeLa cells by linking m6A recognition to the export adaptor SRSF3 and the export receptor NXF1. Knockdown of YTHDC1 causes nuclear accumulation and cytoplasmic depletion of its target transcripts, independent of pre-mRNA splicing.
Key findings
- Knockdown of YTHDC1 increased nuclear m6A levels and extended the apparent half-life of nuclear mRNA methylation more than 2-fold after transcription inhibition; YTHDF2 knockdown extended cytoplasmic m6A apparent half-life by ~4-fold.
- YTHDC1 knockdown did not change total mRNA m6A/A but caused nuclear accumulation and cytoplasmic depletion of m6A and polyA RNA; overexpression of YTHDC1 after YTHDF2 knockdown increased cytoplasmic m6A.
- YTHDC1 targets were defined as transcripts bound in PAR-CLIP and enriched at least 2-fold in RIP-seq, yielding over 700 targets; upon YTHDC1 knockdown, target abundance increased in nuclear RNA and decreased in cytoplasmic RNA, while total target abundance was unchanged.
- YTHDC1 interacts with SRSF3, and SRSF3 interacts with NXF1; YTHDC1 knockdown reduced m6A enrichment by SRSF3 and abolished m6A enrichment by NXF1. Only transcripts bound by both YTHDC1 and SRSF3 showed significant nuclear accumulation upon YTHDC1 knockdown.
- YTHDC1 knockdown affected alternative splicing, with 426 events at Δpsi ≥0.2; 85/737 (11.5%) occurred in YTHDC1 targets versus 108/4,848 (2.2%) in non-targets, but reporter assays showed export effects independent of splicing and m6A binding.
Methods
- HeLa cells were used for siRNA knockdown, plasmid transfection, cellular fractionation, and RNA isolation; m6A/A was quantified by LC-MS/MS on polyA-selected, ribosomal RNA-depleted mRNA from total, nuclear, and cytoplasmic fractions.
- RNA substrates were identified by YTHDC1 PAR-CLIP and RIP-seq, subcellular transcriptomes by RNA-seq after YTHDC1 knockdown, and binding by SRSF3/NXF1 by CLIP or RIP followed by LC-MS/MS and sequencing.
- Mechanistic tests included endogenous and FLAG immunoprecipitation, western blotting, polyA FISH, nascent RNA labeling with 5-ethynyl uridine, RT-qPCR, and a Tet-inducible BoxB-luciferase reporter tethering assay with full-length, N-terminal, C-terminal, and W377A YTHDC1 constructs.
Limitations
- The paper does not include a dedicated limitations section.
- Evident from the text: most experiments are in HeLa cells, so generality to other cell types or organisms is not established.
- The m6A/A measurements are ensemble bulk measurements; the paper notes this allows relative clearance comparisons without determining absolute half-lives of individual mRNAs.
- Export conclusions rely heavily on knockdown/overexpression and tethering assays; the reporter system is splicing-independent and methylation-independent due to BoxB–lambda peptide binding, which the authors present as an advantage but which also means it does not test endogenous m6A-dependent export directly.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



















Verification
Claims the paper makes
0 Valid · 0 Not valid · 19 Not checked · 124 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Upon knockdown of YTHDC1, we observed nuclear accumulation of nascent mRNA for both APC and MCL1 transcripts compared to control, whereas the difference in nuclear SOX12 mRNA abundance was modest and not significant in our assay (Figure 4A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 mediates nuclear export of nascent mRNA
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We show that upon knockdown of YTHDC1, mature mRNA localization is perturbed independently of a splicing requirement or splicing outcomes.”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Discussion > m6A selectivity in nuclear mRNA processing and export
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We observed enrichment of m6A in mRNA bound by SRSF3 under both conditions.”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 facilitates RNA binding to SRSF3 and NXF1
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although YTHDC1 interacts with SRSF3, we did not observe any direct interaction between YTHDC1 and the export receptor NXF1, nor did we observe interaction between YTHDC1 and the common mRNA adaptor protein ALYREF (Figure 5A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 bridges m6A selectivity to mRNA export via SRSF3
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knockdown of YTHDC1 does not affect the m6A/A ratio in mRNA transcripts from whole cell lysate, but results in accumulation of m6A in nuclear mRNA and in an accompanying cytoplasmic depletion of m6A levels (Figure 2A).”
§ YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs > Results > YTHDC1 mediates nuclear to cytoplasmic transport of methylated mRNAs
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
82 more claims
Create a free account to see all 143 claims and to verify the 17 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 35
- The quote only partly states this claim. 1
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,167
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dominissini, D., Moshitch-Moshkovitz, S., Schwartz, S., Salmon-Divon, M., Ungar, L., Osenberg, S., Cesarkas, K., Jacob-Hirsch, J., Amariglio, N., Kupiec, M., et al. (2012) · Nature · doi:10.1038/nature11112 · Cited by 4,884
N6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558 · cited 5×
“Firefly luciferase was fused to five copies of the BoxB sequence and placed under control of a Tet-off promoter (Wang et al., 2014a).”
BackgroundMethodInfluentialSelf-citationALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Zheng, G., Dahl, J. A., Niu, Y., Fedorcsak, P., Huang, C.-M., Li, C. J., Vågbø, C. B., Shi, Y., Wang, W.-L., Song, S.-H., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.015 · Cited by 3,550
Self-citation
Cited by
Items 901–1,000 of 1,260
The role of m6A mRNA modification in normal and malignant hematopoiesis
Ma, Z., Sugimura, R., & Lui, K. O. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad061 · Cited by 6
Transcriptome-wide m6A methylation in natural yellow leaf of Catalpa fargesii
Zhang, Y., Wang, J., Ma, W., Lü, N., Fu, P., Yang, Y., Zhao, L., Hu, J., Qu, G., & Wang, N. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1167789 · Cited by 6
Talic, E., Wooten, A., Zeczycki, T. N., & Mansfield, K. D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45070346 · Cited by 6
CRISPR-based m6A modification and its potential applications in telomerase regulation
Yi, M., Wang, M., Xu, Y., Cao, Z., Ling, Y., Zhang, Z., & Cao, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1200734 · Cited by 6
Self-citationXu, G.-E., Zhao, X., Li, G., Gokulnath, P., Wang, L., & Xiao, J. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.015 · Cited by 6
RNA Modifications in Cancer Metabolism and Tumor Microenvironment
Qing, Y., Dong, W., Deng, X., Chen, J., & Su, R. J. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-45654-1_1 · Cited by 6
RNA modifications in gynecological cancer: current status and future directions
He, W., Hong, X., Chen, G., Luo, X., & Lin, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1314075 · Cited by 6
Yang, J., Liang, F., Zhang, F., Zhao, H., Gong, Q., & Gao, N. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108671 · Cited by 6
RNA N6-methyladenosine methylation in influenza A virus infection
Liu, X., Chen, W., Li, K., & Sheng, J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1401997 · Cited by 6
Role of RNA modifications in blood development and regeneration
Gunage, R. D., & Zon, L. I. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104279 · Cited by 6
Complicated role of ALKBH5 in gastrointestinal cancer: an updated review
Shu, W., Huang, Q., Chen, R., Lan, H., Yu, L., Cui, K., He, W., Zhu, S., Chen, M., Li, L., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03480-5 · Cited by 6
Epigenetic Mechanisms in Osteoporosis: Exploring the Power of m6A RNA Modification
Tian, S., Song, Y., Guo, L., Hui, Z., Bai, M., & Miao, M. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70344 · Cited by 6
The role of N(6)-methyladenosine (m6a) modification in cancer: recent advances and future directions
Xie, X., Fang, Z., Zhang, H., Wang, Z., Li, J., Jia, Y., Shang, L., Cao, F., & Li, F. (2025) · EXCLI journal · doi:10.17179/excli2024-7935 · Cited by 6
Long Non-coding RNAs Diversity in Form and Function: From Microbes to Humans
Chávez‐Calvillo, G., Gan, H., & Sztuba-Solińska, J. (2020) · RNA technologies · doi:10.1007/978-3-030-44743-4_1 · Cited by 6
RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness
Chen, H., Wang, Y., Su, H., Zhang, X., Chen, H., & Yu, J. Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.935224 · Cited by 6
Research progress of m6A regulation during animal growth and development
Yu, H., Raza, S. H. A., Zhang, W., Yang, X., Almohaimeed, H. M., Alshanwani, A. R., Assiri, R., Aggad, W. S., & Zan, L. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101851 · Cited by 6
Emerging role of mRNA methylation in regulating the hallmarks of cancer
Sarraf, G., & Chhabra, R. (2022) · Biochimie · doi:10.1016/j.biochi.2022.10.005 · Cited by 6
Ye, T., Wang, J., Zhao, H., Zhao, G., & Li, P. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5452 · Cited by 6
Lv, Z., Ran, R., Yang, Y., Xiang, M., Su, H., & Huang, J. (2023) · Discover Oncology · doi:10.1007/s12672-023-00695-2 · Cited by 6
Zheng, H., Wu, D., Chen, X., He, W., Hua, J., Li, Q., & Ji, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24963 · Cited by 6
Chen, D., Zang, L., Zhou, Y., Yang, Y., Zhang, X., Li, Z., Shu, Y., Gao, W., Zhu, H., & Yu, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28243 · Cited by 6
Pei, D., Xu, C., Wang, D., Shi, X., Zhang, Y., Liu, Y., Liu, N., Guo, J., Yu, Y. W., Kang, Z., et al. (2022) · Journal of Oncology · doi:10.1155/2022/2910491 · Cited by 6
Yao, J., Lin, M.-X., Liao, W., Fan, W.-J., Xu, X.-X., Shi, H., & Wu, S.-X. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709269 · Cited by 6
Ticket to divide: m6A reader YTHDC1 drives acute myeloid leukemia proliferation
Volk, A. G. (2021) · Blood · doi:10.1182/blood.2021013185 · Cited by 6
Decoding the regulatory roles of circular RNAs in cardiac fibrosis
You, Q., Yu, J., Pan, R., Feng, J., Guo, H.-D., & Liu, B. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.11.007 · Cited by 5
Bao, R., Guo, T., Yang, Z., Feng, C., Wu, J., Fu, X., Liu, H., Liu, C., & Ma, F. (2025) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2025.01.001 · Cited by 5
Feng, B., Chen, Y., Tu, H., Zhang, J., Tong, L., Lyu, X., Irving, A. T., & Chen, D. (2025) · Stem Cells · doi:10.1093/stmcls/sxaf032 · Cited by 5
Dong, S., Pang, J., Wang, Y., Han, L. K., Zhou, X., Huang, F., Zhang, S., Ma, N., Huang, H., & Weng, H. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115802 · Cited by 5
Tian, Y., Peng, J., Zhou, J., Yang, W., Peng, Y., Li, J., Rui, Y., Zhang, H., Xie, G., Wang, H., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2897-y · Cited by 5
Natalí, L., de la Cruz-Thea, B., Godino, A., Conde, C. B., Peinado, V. I., & Musri, M. M. (2026) · Biomolecules · doi:10.3390/biom16010173 · Cited by 5
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse models
Zhang, H., Li, Y., Zhao, Y., Wang, F., Lin, G., Niu, T., Li, H., Li, Y., Liu, L. Z., Liang, Y., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adu3137 · Cited by 5
Genetic variants associated mRNA stability in lung
Lǐ, J., Tang, M., Li, Y., Amos, C. I., & Cheng, C. (2022) · BMC Genomics · doi:10.1186/s12864-022-08405-y · Cited by 5
Baron, F., Zhang, M., Archer, N., Bellows, E., Knight, H. M., Welham, S. J. M., Rutland, C. S., Mongan, N. P., Hayes, C. J., Fray, R. G., et al. (2023) · RNA · doi:10.1261/rna.079615.123 · Cited by 5
Reading the epitranscriptome of the human malaria parasite
Govindaraju, G., & Rajavelu, A. (2024) · Biomedical Journal · doi:10.1016/j.bj.2024.100703 · Cited by 5
Genetic regulation of m6A RNA methylation and its contribution in human complex diseases
Chen, K., Nan, J., & Xiong, X. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2609-8 · Cited by 5
Role of AMIGO2 in cancer progression: Novel insights (Review)
Tian, Z., Zhou, D., Jiang, R., & Zhou, B. (2024) · Oncology Letters · doi:10.3892/ol.2024.14567 · Cited by 5
Epitranscriptome: A Novel Regulatory Layer during Atherosclerosis Progression
Schiano, C., Trama, U., Coscioni, E., Infante, T., Coppola, A., de Nigris, F., & Claudio Napoli, A. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673322775240822051304 · Cited by 5
When animal viruses meet N6-methyladenosine (m6A) modifications: for better or worse?
Wang, W., Jin, Y., Xie, Z., He, M., Li, J., Wang, Z., Ma, S.-Y., Zhang, W., & Tong, J. (2024) · Veterinary Research · doi:10.1186/s13567-024-01424-5 · Cited by 5
Ma, L., Tao, X., Fahim, A. M., Xu, Y., Zhang, Y., Li, S., Yang, G., Pu, Y., Wang, W., Liu, L., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140460 · Cited by 5
Settas, N., Bittel, A. J., & Chen, Y.-W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115170 · Cited by 5
The Essential Role of Epigenetic Modifications in Neurodegenerative Diseases with Dyskinesia
Qi, Z., Li, J., Li, M., Du, X., Zhang, L., Wang, S., Xu, B., Liu, W., Xu, Z., & Deng, Y. L. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01133-z · Cited by 5
Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
Zhang, Y., Zhan, L., Li, J., Jiang, X., & Li, Y. (2023) · Aging · doi:10.18632/aging.204679 · Cited by 5
N6-Methyladenosine in Vascular Aging and Related Diseases: Clinical Perspectives
Li, C., Liu, L., Li, S., & Liu, Y. (2023) · Aging and Disease · doi:10.14336/ad.2023.0924-1 · Cited by 5
The role of N6-methyladenosine methylation in PAHs-induced cancers
Wei, Y., Guo, X., Li, L., Xue, W., Wang, L., Chen, C., Sun, S., Yang, Y., Yao, W., Wang, W., et al. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-30710-6 · Cited by 5
Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis
Jin, T., Wang, H., Liu, Y., & Wang, H. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02413-5 · Cited by 5
The role of RNA modifications in disease-associated macrophages
Huart, C., Gupta, M. S., & Ginderachter, J. A. V. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102315 · Cited by 5
Rupareliya, M., & Shende, P. K. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_820 · Cited by 5
Cao, L., Huang, G., Fan, J., Liu, X., & Ma, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1458884 · Cited by 5
An Epigenetic Spin to ALS and FTD
Ebbert, M., Lank, R. J., & Belzil, V. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_1 · Cited by 5
N6-methyladenosine RNA modifications: a potential therapeutic target for AML
Hu, R., Liao, P., Xu, B., Qiu, Y., Zhang, H., & Li, Y. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05302-6 · Cited by 5
The Functions of N-methyladenosine (m6A) Modification on HIV-1 mRNA
Zhong, X., Zhou, Z., & Yang, G. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01280-2 · Cited by 5
Navigating the landscape of epitranscriptomics and host immunityPreprint
Huang, E., Frydman-Gani, C., & Xiao, X. G. (2024) · Genome Research · doi:10.1101/gr.278412.123 · Cited by 5
Zhou, Z., Wang, Y., Zheng, X., Zhang, X., Ji, L., Han, J.-Y., Zuo, Z., Mo, W., & Zhang, L. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2707-9 · Cited by 4
Cosseddu, C., Succu, S., Frau, A., Mossa, F., Versace, S. V., Brevini, T. A. L., Ledda, S., & Bebbere, D. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03444-2 · Cited by 4
Functional nucleic acid-based biosensing for m6A-modifying enzyme activity monitoring
Chen, Z., Zhang, X., Ping, H., & Ge, M. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118485 · Cited by 4
RNA modifications in cancer: from biological insights to therapeutic targets
Zhao, Y., & He, C. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118432 · Cited by 4
Self-citationMa, C., Wang, D., Gao, W., Wang, X., Xu, X., Jia, J., & Liu, Z. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112244 · Cited by 4
Self-citationLactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3
Zhang, F., Zeng, L.-H., Zou, K., Lin, K., Yao, F., Song, J., Zhang, S., Feng, H., Yang, Z., Wang, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202510192 · Cited by 4
Naquin, D., Blanchet, S., van Dijk, E., Bertrand, L., Grégoire, S., Ramírez, B. C., Ouazahrou, R., Jaszczyszyn, Y., Moris, A., Thermes, C., et al. (2025) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaf200 · Cited by 4
Chen, Y.-S., Dong, J., Tan, W., Liu, H., Zhang, S., Zou, J., Chen, Y., Bai, S.-Y., & Zeng, Y. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114586 · Cited by 4
The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
Zhang, Y., Gu, W., & Shao, Y. (2023) · Discover Oncology · doi:10.1007/s12672-023-00759-3 · Cited by 4
The mRNA N6-Methyladenosine Response to Dehydration in Xenopus laevis
Rehman, S., Parent, M., & Storey, K. B. (2024) · Animals · doi:10.3390/ani14223288 · Cited by 4
Dual roles of N6-methyladenosine in R-loop regulation of gene transcription and genome stability
Li, F., Zhang, F., Li, J., Zhang, Y., Gong, W., Zhang, Y., Liu, M., Ren, J., & Han, D. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2947-6 · Cited by 4
Qi, C., Jin, X., Wang, H., & Xu, D. (2025) · Biomolecules · doi:10.3390/biom15081092 · Cited by 4
The critical role of OsYTH10 in promoting early flowering of rice under long sunlight
Yang, J., Chen, Z., Wang, P., Nyasulu, M., Cheng, Q., He, X., Xu, J., Fu, J., Zhou, D., Ouyang, L., et al. (2025) · Theoretical and Applied Genetics · doi:10.1007/s00122-025-05041-4 · Cited by 4
Nuclear 2′- O -methylation regulates RNA splicing through its binding protein FUBP1
Gao, B., Jiang, B., Zou, Z., Liu, B., Liu, W., Chen, L., Zhang, L., & He, C. (2025) · Science Advances · doi:10.1126/sciadv.ady3894 · Cited by 4
Self-citationRNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
Cheng, C., Wu, Y., Wang, X., Xue, Q., Huang, Y., Liao, F., Wang, X., Duan, Q., & Miao, C. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01066-8 · Cited by 4
Self-citationThe m6A ‐independent role of epitranscriptomic factors in cancer
Bove, G., Crepaldi, M., Amin, S., Megchelenbrink, W., Nebbioso, A., Carafa, V., Altucci, L., & Gaudio, N. D. (2024) · International Journal of Cancer · doi:10.1002/ijc.35067 · Cited by 4
Yuan, Z., Lei, Y., Wan, B., Yang, M., Jiang, Y., Tian, C., Wang, Z., & Wang, W. (2024) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2024.101307 · Cited by 4
The m6A regulators in prostate cancer: molecular basis and clinical perspective
Cao, Y. J., Jia, M., Duan, C., Yang, Z., Cheng, B., & Wang, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1448872 · Cited by 4
The role of N6-methyladenosine modification in tumor angiogenesis
Li, Q., Zeng, X., Qiu, X., Chen, X., & Liu, S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1467850 · Cited by 4
Dynamic Roles of RNA and RNA Epigenetics in HTLV-1 Biology
King, E. M., & Panfil, A. R. (2025) · Viruses · doi:10.3390/v17010124 · Cited by 4
Machine learning–augmented m6A-Seq analysis without a reference genome
Yang, J., Song, M., Bu, Y., Zhao, H., Liu, C., Zhang, T., Zhang, C., Xu, S., & Ma, C. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf235 · Cited by 4
Chen, P., Hu, J., Han, X., & Chen, Y. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07126-5 · Cited by 4
Sequence-specific targeting of RNA
Rösner, L., Reichert, D., Rau, K., Muthmann, N., & Rentmeister, A. (2022) · Methods · doi:10.1016/j.ymeth.2022.06.007 · Cited by 4
Critical functions of N6-adenosine methylation of mRNAs in T cells
Ito-Kureha, T., & Heissmeyer, V. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119380 · Cited by 4
Analysis approaches for the identification and prediction of N 6 -methyladenosine sites
Yang, Y., Liu, Z., Lu, J., Sun, Y., Fu, Y., Pan, M., Xie, X., & Ge, Q. (2022) · Epigenetics · doi:10.1080/15592294.2022.2158284 · Cited by 4
Liu, W., Su, F., Gao, K., Chen, D., & Li, Z. (2023) · Chemical Communications · doi:10.1039/d3cc03098a · Cited by 4
Wang, X., Gan, M., Wang, Y., Wang, S., Lei, Y., Wang, K., Zhang, X., Chen, L., Zhao, Y., Niu, L., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132057 · Cited by 4
Self-citationEpitranscriptomic Signatures in Neural Development and Disease
Sharma, S., & Lenka, N. (2021) · RNA technologies · doi:10.1007/978-3-030-71612-7_3 · Cited by 4
Diensthuber, G., Pryszcz, L. P., Llovera, L., Lucas, M. C., Delgado-Tejedor, A., Cruciani, S., Roignant, J., Begik, O., & Novoa, E. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568965 · Cited by 4
Dynamics and regulatory roles of RNA m6A methylation in unbalanced genomesPreprint
Zhang, S., Wang, R., Luo, K., Gu, S., Liu, X., Wang, J., Zhang, L., & Sun, L. (2024) · eLife · doi:10.7554/elife.100144 · Cited by 4
N6‐Methyladenosine in Mammalian Messenger RNA: Function, Location, and Quantitation
Ge, R., He, M. E., & Tang, W. (2024) · Israel Journal of Chemistry · doi:10.1002/ijch.202300181 · Cited by 3
Liu, X., Zhang, L., Chen, J., & Shao, W. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111745 · Cited by 3
Sayed, S. B., Rabbi, M. A., Debnath, J. P., Hossen, K., & Ghosh, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328773 · Cited by 3
Interactions between ALKBH5 and reader proteins in tumors: functions and molecular mechanisms
Ou, J., Liu, B., Yu, Y., He, Y., Gao, Y., Chen, L., Chen, X., & Tao, H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1611007 · Cited by 3
Liu, T., Yang, X., Zhou, L., Gan, M., He, T., Hong, S., Feng, Y., Su, G., Zhao, Y., Cao, Y., et al. (2025) · Ibrain · doi:10.1002/ibra.70000 · Cited by 3
Yuan, H., Ge, G., Liu, L., Hu, S., Tian, M., Nie, Y., Zhao, Z., & Song, Y. (2025) · Advanced Science · doi:10.1002/advs.202509574 · Cited by 3
Uli-epic: profiling RNA modifications from ultra-low input samples
He, W., Xu, C., Chen, W., Xiao, J., Wang, Y., Peng, Y., Chang, S., Zhu, W., Kang, J., & Hu, L. (2025) · Genome biology · doi:10.1186/s13059-025-03857-3 · Cited by 3
RNA Modifications in T cell Immunity: Mechanisms, Disease Relevance, and Therapeutic Potential
Zhao, X., Zou, M., Feng, W., Li, N., Chen, X., Lin, P., Zhou, Z., Lin, Y., & Cui, L. (2025) · Theranostics · doi:10.7150/thno.124482 · Cited by 3
Inamoto, T., Nakano, M., Fukami, T., & Nakajima, M. (2026) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2026.101519 · Cited by 3
Li, C., Jiang, X., Yuan, Y., Chen, X., Pu, S., Lian, K., Li, L., & Wang, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1694842 · Cited by 3
The LkMTA2 / LkMTB8 – LkERF1 – LkEXPA8 cascade regulates xylem cell expansion in larch
Lyu, Z., Xie, Y. J., Zhang, K., Han, H., Zhang, S., & Sun, X. (2026) · New Phytologist · doi:10.1111/nph.71021 · Cited by 3
Radhi, M., Rowlinson, J., Walker, L., Deacon, S., Knight, H. M., & Smith, S. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041967 · Cited by 3
N6-adenosine methylation enhances nuclear mRNA export through METTL3 and NUP93
Lee, J. H., Tingey, M., Zhang, Z., Buerger, F., Hong, J., Zhang, G., Yang, M., Du, B., Jeong, J.-H., John, K. A., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01882-3 · Cited by 3
Self-citationRoss, S. E., Holliday, H., Wang, E., Zeraati, M., Tsoli, M., Ziegler, D. S., & Dinger, M. E. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08647-8 · Cited by 3
m6A in RNA: a key regulator of brain development, function and disease
Sivasudhan, E., & Meyer, K. D. (2026) · Nature reviews. Neuroscience · doi:10.1038/s41583-026-01056-y · Cited by 3
Shimanski, B. A., Marín, J. F., Warmiński, M., Eluwawalage, K. D. A., Calzini, L. O., McKeon, R. M., Kowalska, J., Jemielity, J., Hadden‐Perilla, J. A., & Mugridge, J. S. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113573 · Cited by 3
m6A‑SNP: From genetics to epigenetics (Review)
Niu, C.-X., & Zhou, R. (2022) · International Journal of Epigenetics · doi:10.3892/ije.2022.13 · Cited by 3
Mensah, I. K., Norvil, A. B., He, M., Lendy, E. K., Hjortland, N. M., Tan, H. J., Pomerantz, R. T., Mesecar, A. D., & Gowher, H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105257 · Cited by 3
Metadata
- Authors
- Roundtree, I. A., Luo, G.-Z., Zhang, Z., Wang, X., Zhou, T., Cui, Y., Sha, J., Huang, X., Guerrero, L., Xie, P., He, E., Shen, B., & He, C.
- Affiliations
- Howard Hughes Medical Institute (US)
- ShanghaiTech University (CN)
- State Key Laboratory of Reproductive Medicine (CN)
- University of Chicago (US)
- Corresponding author
- Shen, Bin
- He, Chuan
- ORCID
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2017-10-06
- Volume
- 6
- ISSN
- 2050-084X (ISSN-L)
- PMC
- PMC5648532
- OpenAlex
- W2764301500
- Cited by
- 1,256
- References
- 59
- Citations by year
- 2026: 99 · 2025: 163 · 2024: 199 · 2023: 198 · 2022: 201 · 2021: 181 · 2020: 114 · 2019: 57 · 2018: 43
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- eLife (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Chicago (cc-by)
- Funders
- National Institute of General Medical Sciences (F30GM117646, HG008688, GM113194)
- Howard Hughes Medical Institute
- National Science Foundation (CHE-1048528)
- National Natural Science Foundation of China (31171377, 31471400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- YTHDC1, N6-methyladenosine, m6A reader proteins, mRNA export, mRNA splicing, SRSF3, NXF1, mRNA modification, RNA metabolism
- MeSH terms
- Serine-Arginine Splicing Factors, RNA Splicing Factors, Adenosine, HeLa Cells, Humans, Nerve Tissue Proteins, Protein Binding, RNA, Messenger, RNA-Binding Proteins, Active Transport, Cell Nucleus, Nucleocytoplasmic Transport Proteins, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-13, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-13 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.